rs1042116

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001290043.2(TAP2):​c.1308C>T​(p.Asn436Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0988 in 1,612,240 control chromosomes in the GnomAD database, including 9,114 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.080 ( 691 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8423 hom. )

Consequence

TAP2
NM_001290043.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.10

Publications

16 publications found
Variant links:
Genes affected
TAP2 (HGNC:44): (transporter 2, ATP binding cassette subfamily B member) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. This gene is located 7 kb telomeric to gene family member ABCB2. The protein encoded by this gene is involved in antigen presentation. This protein forms a heterodimer with ABCB2 in order to transport peptides from the cytoplasm to the endoplasmic reticulum. Mutations in this gene may be associated with ankylosing spondylitis, insulin-dependent diabetes mellitus, and celiac disease. Alternative splicing of this gene produces products which differ in peptide selectivity and level of restoration of surface expression of MHC class I molecules. [provided by RefSeq, Feb 2014]
TAP2 Gene-Disease associations (from GenCC):
  • MHC class I deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 6-32830771-G-A is Benign according to our data. Variant chr6-32830771-G-A is described in ClinVar as Benign. ClinVar VariationId is 403516.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.1 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.107 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAP2NM_001290043.2 linkc.1308C>T p.Asn436Asn synonymous_variant Exon 8 of 12 ENST00000374897.4 NP_001276972.1 Q03519-1Q5JNW1
TAP2NM_018833.3 linkc.1308C>T p.Asn436Asn synonymous_variant Exon 8 of 12 NP_061313.2 Q03519-2Q9UP03

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAP2ENST00000374897.4 linkc.1308C>T p.Asn436Asn synonymous_variant Exon 8 of 12 1 NM_001290043.2 ENSP00000364032.3 Q03519-1
ENSG00000250264ENST00000452392.2 linkc.1308C>T p.Asn436Asn synonymous_variant Exon 8 of 15 2 ENSP00000391806.2 E7ENX8

Frequencies

GnomAD3 genomes
AF:
0.0804
AC:
12225
AN:
152024
Hom.:
690
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0225
Gnomad AMI
AF:
0.154
Gnomad AMR
AF:
0.0632
Gnomad ASJ
AF:
0.0660
Gnomad EAS
AF:
0.0166
Gnomad SAS
AF:
0.0284
Gnomad FIN
AF:
0.204
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.109
Gnomad OTH
AF:
0.0684
GnomAD2 exomes
AF:
0.0814
AC:
19968
AN:
245250
AF XY:
0.0809
show subpopulations
Gnomad AFR exome
AF:
0.0205
Gnomad AMR exome
AF:
0.0408
Gnomad ASJ exome
AF:
0.0604
Gnomad EAS exome
AF:
0.0130
Gnomad FIN exome
AF:
0.198
Gnomad NFE exome
AF:
0.107
Gnomad OTH exome
AF:
0.0830
GnomAD4 exome
AF:
0.101
AC:
147128
AN:
1460098
Hom.:
8423
Cov.:
37
AF XY:
0.0986
AC XY:
71643
AN XY:
726290
show subpopulations
African (AFR)
AF:
0.0193
AC:
646
AN:
33474
American (AMR)
AF:
0.0424
AC:
1892
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
0.0597
AC:
1560
AN:
26122
East Asian (EAS)
AF:
0.0352
AC:
1398
AN:
39698
South Asian (SAS)
AF:
0.0293
AC:
2522
AN:
86136
European-Finnish (FIN)
AF:
0.195
AC:
10187
AN:
52270
Middle Eastern (MID)
AF:
0.0260
AC:
150
AN:
5766
European-Non Finnish (NFE)
AF:
0.111
AC:
123717
AN:
1111622
Other (OTH)
AF:
0.0838
AC:
5056
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
8431
16862
25294
33725
42156
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4350
8700
13050
17400
21750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0804
AC:
12229
AN:
152142
Hom.:
691
Cov.:
32
AF XY:
0.0839
AC XY:
6242
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.0225
AC:
933
AN:
41528
American (AMR)
AF:
0.0630
AC:
964
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0660
AC:
229
AN:
3468
East Asian (EAS)
AF:
0.0164
AC:
85
AN:
5178
South Asian (SAS)
AF:
0.0290
AC:
140
AN:
4828
European-Finnish (FIN)
AF:
0.204
AC:
2151
AN:
10560
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.109
AC:
7432
AN:
67970
Other (OTH)
AF:
0.0682
AC:
144
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
548
1096
1645
2193
2741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0945
Hom.:
1992
Bravo
AF:
0.0669
Asia WGS
AF:
0.0220
AC:
76
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

MHC class I deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 16, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
3.1
DANN
Benign
0.49
PhyloP100
-2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1042116; hg19: chr6-32798548; COSMIC: COSV66501383; COSMIC: COSV66501383; API